Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Rich Pharmaceuticals Inc RCHA

Rich Pharmaceuticals Inc is a United States based development stage biopharmaceutical company. It is focused on the development on RP-323 for the treatment of Hodgkin's lymphoma (HL), Acute Myelogenous Leukemia (AML), and to cause elevation of white blood cells in the patients depleted of these elements due to various conditions. RP-323 is a naturally occurring compound that has properties... see more

Bullboard (OTCPK:RCHA)

View:
Post by reddeermanon Mar 21, 2017 6:07pm

re:HUGE VOLUME

Should be RCHA not RCHAE
Post by reddeermanon Mar 21, 2017 5:55pm

HUGE VOLUME

Maybe worth checkiing out getting into the cannabis game. Large o/s tho
Post by iMarketcheck13on Feb 06, 2015 11:35pm

Next big thing?!

This thing is going to either explode in a few weeks or drop.... Worth the risk ? 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities